Bhatnagar, Deepak

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Mathieu, C., Dandona, P., Gillard, P., Senior, P., Hasslacher, C., Araki, E., Lind, M., Bain, S. C., Jabbour, S., Arya, N., et al. (2018) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 252

The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy

Panthakalam, S., Bhatnagar, D., & Klimiuk, P. (2004) · Scottish Medical Journal

Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and Disorders

Cited by 69

Effect of a New Fish Oil Concentrate (OMACOR) on Plasma Lipids and Lipoproteins in Patients with Hypertriglyceridaemia

MacKness, M. I., Bhatnagar, D., Prais, H., Haynes, B., Morgan, J., & Durrington, P. N. (1995) · Clinical Science

Fatty Acid Research and HealthLipid metabolism and disorders

Cited by 0